APA (7th ed.) Citation

Weber, M., Kodjikian, L., Coscas, F., Faure, C., Aubry, I., Dufour, I., & Cohen, S. Y. (2020). Impact of intravitreal aflibercept dosing regimens in treatment-naïve patients with neovascular age-related macular degeneration in routine clinical practice in France: Results from the RAINBOW study. BMJ open ophthalmology, 5(1), e000377. https://doi.org/10.1136/bmjophth-2019-000377

Chicago Style (17th ed.) Citation

Weber, Michel, Laurent Kodjikian, Florence Coscas, Céline Faure, Isabelle Aubry, Ingrid Dufour, and Salomon Y. Cohen. "Impact of Intravitreal Aflibercept Dosing Regimens in Treatment-naïve Patients with Neovascular Age-related Macular Degeneration in Routine Clinical Practice in France: Results from the RAINBOW Study." BMJ Open Ophthalmology 5, no. 1 (2020): e000377. https://doi.org/10.1136/bmjophth-2019-000377.

MLA (9th ed.) Citation

Weber, Michel, et al. "Impact of Intravitreal Aflibercept Dosing Regimens in Treatment-naïve Patients with Neovascular Age-related Macular Degeneration in Routine Clinical Practice in France: Results from the RAINBOW Study." BMJ Open Ophthalmology, vol. 5, no. 1, 2020, p. e000377, https://doi.org/10.1136/bmjophth-2019-000377.